DVAX
Price
$10.12
Change
-$0.15 (-1.46%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
1.19B
62 days until earnings call
IMCC
Price
$2.32
Change
-$0.12 (-4.92%)
Updated
Aug 29, 04:59 PM (EDT)
Capitalization
12.8M
Interact to see
Advertisement

DVAX vs IMCC

Header iconDVAX vs IMCC Comparison
Open Charts DVAX vs IMCCBanner chart's image
Dynavax Technologies
Price$10.12
Change-$0.15 (-1.46%)
Volume$24.21K
Capitalization1.19B
IM Cannabis
Price$2.32
Change-$0.12 (-4.92%)
Volume$200
Capitalization12.8M
DVAX vs IMCC Comparison Chart in %
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. IMCC commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and IMCC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (DVAX: $10.27 vs. IMCC: $2.44)
Brand notoriety: DVAX and IMCC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DVAX: 116% vs. IMCC: 144%
Market capitalization -- DVAX: $1.2B vs. IMCC: $12.8M
DVAX [@Pharmaceuticals: Generic] is valued at $1.2B. IMCC’s [@Pharmaceuticals: Generic] market capitalization is $12.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileIMCC’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • IMCC’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCC is a better buy in the long-term than DVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 4 TA indicator(s) are bullish while IMCC’s TA Score has 3 bullish TA indicator(s).

  • DVAX’s TA Score: 4 bullish, 6 bearish.
  • IMCC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both DVAX and IMCC are a bad buy in the short-term.

Price Growth

DVAX (@Pharmaceuticals: Generic) experienced а -6.21% price change this week, while IMCC (@Pharmaceuticals: Generic) price change was +11.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

DVAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.19B) has a higher market cap than IMCC($12.8M). IMCC YTD gains are higher at: 4.672 vs. DVAX (-19.577). IMCC has higher annual earnings (EBITDA): 3.96M vs. DVAX (-34.26M). DVAX has more cash in the bank: 614M vs. IMCC (794K). IMCC has less debt than DVAX: IMCC (15.6M) vs DVAX (285M). DVAX has higher revenues than IMCC: DVAX (316M) vs IMCC (52.4M).
DVAXIMCCDVAX / IMCC
Capitalization1.19B12.8M9,273%
EBITDA-34.26M3.96M-866%
Gain YTD-19.5774.672-419%
P/E Ratio54.60N/A-
Revenue316M52.4M603%
Total Cash614M794K77,330%
Total Debt285M15.6M1,827%
FUNDAMENTALS RATINGS
DVAX: Fundamental Ratings
DVAX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DVAXIMCC
RSI
ODDS (%)
Bearish Trend 5 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
75%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CAPAX9.18N/A
N/A
Federated Hermes Capital Income A
MFRJX63.06N/A
N/A
MFS Research R4
MPAIX28.73N/A
N/A
Morgan Stanley Inst Advantage I
VRSGX30.50N/A
N/A
Virtus KAR Small-Cap Growth R6
LIGNX11.58N/A
N/A
Loomis Sayles International Growth N

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.10%
ACET - DVAX
39%
Loosely correlated
+0.40%
SNDL - DVAX
35%
Loosely correlated
+6.32%
AMRX - DVAX
33%
Poorly correlated
+2.03%
ESPR - DVAX
32%
Poorly correlated
+1.38%
BCRX - DVAX
32%
Poorly correlated
-0.59%
More

IMCC and

Correlation & Price change

A.I.dvisor tells us that IMCC and CRON have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMCC and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCC
1D Price
Change %
IMCC100%
+7.96%
CRON - IMCC
25%
Poorly correlated
+1.56%
SHIEF - IMCC
25%
Poorly correlated
-5.21%
DVAX - IMCC
23%
Poorly correlated
+0.10%
SCYX - IMCC
22%
Poorly correlated
+1.76%
SNDL - IMCC
22%
Poorly correlated
+6.32%
More